Clinuvel Pharmaceuticals Limited (CUV.AX)
AUD 11.94
(-0.5%)
AUD 11.94
(-0.5%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 879.78 Thousand AUD | -12.01% |
| 2023 | 999.86 Thousand AUD | -20.43% |
| 2022 | 1.25 Million AUD | -3.6% |
| 2021 | 1.3 Million AUD | -1.22% |
| 2020 | 1.31 Million AUD | 205.09% |
| 2019 | 432.51 Thousand AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | 0.0% |
| 2008 | - AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| 2006 | - AUD | 0.0% |
| 2005 | - AUD | 0.0% |
| 2004 | - AUD | 0.0% |
| 2003 | - AUD | 0.0% |
| 2002 | - AUD | 0.0% |
| 2001 | - AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.06 Million AUD | 0.0% |
| 2024 Q4 | 879.78 Thousand AUD | 0.0% |
| 2024 FY | 879.78 Thousand AUD | -12.01% |
| 2023 FY | 999.86 Thousand AUD | -20.43% |
| 2023 Q2 | 1.13 Million AUD | 0.0% |
| 2023 Q4 | 999.86 Thousand AUD | 0.0% |
| 2022 FY | 1.25 Million AUD | -3.6% |
| 2022 Q4 | 1.25 Million AUD | 0.0% |
| 2022 Q2 | 1.16 Million AUD | 0.0% |
| 2021 Q4 | 1.3 Million AUD | 0.0% |
| 2021 FY | 1.3 Million AUD | -1.22% |
| 2021 Q2 | 1.37 Million AUD | 0.0% |
| 2020 Q4 | 1.31 Million AUD | 0.0% |
| 2020 Q2 | 308.05 Thousand AUD | 0.0% |
| 2020 FY | 1.31 Million AUD | 205.09% |
| 2019 FY | 432.51 Thousand AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 Q4 | 432.51 Thousand AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2014 Q2 | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| 2013 Q3 | - AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2013 Q1 | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2009 FY | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2008 FY | - AUD | 0.0% |
| 2008 Q4 | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2006 FY | - AUD | 0.0% |
| 2006 Q4 | - AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| 2005 Q4 | - AUD | 0.0% |
| 2004 Q4 | - AUD | 0.0% |
| 2004 FY | - AUD | 0.0% |
| 2003 Q4 | - AUD | 0.0% |
| 2003 FY | - AUD | 0.0% |
| 2002 FY | - AUD | 0.0% |
| 2002 Q4 | - AUD | 0.0% |
| 2001 FY | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 123.85 Thousand AUD | -610.328% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Zelira Therapeutics Limited | 5.65 Million AUD | 84.438% |
| Biome Australia Limited | 1.3 Million AUD | 32.621% |
| Patrys Limited | - AUD | -Infinity% |
| Orthocell Limited | 689.69 Thousand AUD | -27.562% |
| Imugene Limited | 1.54 Million AUD | 43.127% |
| Noxopharm Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | 1.11 Million AUD | 20.939% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| Prescient Therapeutics Limited | 330.48 Thousand AUD | -166.209% |
| Proteomics International Laboratories Limited | 316.39 Thousand AUD | -178.065% |
| Cynata Therapeutics Limited | - AUD | -Infinity% |
| CSL Limited | 18.24 Billion AUD | 99.995% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Starpharma Holdings Limited | 3.52 Million AUD | 75.063% |
| Nanollose Limited | 42.53 Thousand AUD | -1968.62% |
| Memphasys Limited | 4.41 Million AUD | 80.065% |
| Invex Therapeutics Ltd | - AUD | -Infinity% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | 1.56 Million AUD | 43.666% |
| Botanix Pharmaceuticals Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | 421.96 Thousand AUD | -108.495% |
| Race Oncology Limited | - AUD | -Infinity% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 17.44 Million AUD | 94.957% |
| Dimerix Limited | 149.68 Thousand AUD | -487.765% |
| PharmAust Limited | - AUD | -Infinity% |
| Immutep Limited | 1.22 Million AUD | 28.372% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 159.04 Thousand AUD | -453.167% |
| BTC Health Limited | - AUD | -Infinity% |
| Acrux Limited | 1.48 Million AUD | 40.835% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Biotron Limited | 7130.00 AUD | -12239.187% |
| Tissue Repair Ltd | - AUD | -Infinity% |
| AdAlta Limited | 2.49 Million AUD | 64.732% |
| Radiopharm Theranostics Limited | - AUD | -Infinity% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 23.59 Thousand AUD | -3629.162% |
| Paradigm Biopharmaceuticals Limited | 239.33 Thousand AUD | -267.603% |
| Recce Pharmaceuticals Ltd | 811.19 Thousand AUD | -8.456% |
| Avecho Biotechnology Limited | 175.15 Thousand AUD | -402.3% |
| Actinogen Medical Limited | 319.06 Thousand AUD | -175.735% |
| Immuron Limited | 173.49 Thousand AUD | -407.089% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |